{
    "title": "Witty gives troubled Glaxo a different dose",
    "url": "https://www.dailymail.co.uk/money/markets/article-1637691/Witty-gives-troubled-Glaxo-a-different-dose.html",
    "date": "2008-07-24",
    "keywords": [
        "gsk",
        "share",
        "presence",
        "development",
        "board",
        "venture",
        "drug",
        "glaxo",
        "dose",
        "lyall",
        "mailonline",
        "gmt",
        "july",
        "view",
        "executive",
        "break",
        "buyback",
        "deal",
        "predecessor",
        "jeanpierre",
        "market",
        "prescription",
        "copycat",
        "competition",
        "number",
        "blockbuster",
        "performance",
        "world",
        "firm",
        "exchange",
        "treatment",
        "avandia",
        "drag",
        "quarter",
        "dividend",
        "appearance",
        "misfiring",
        "method",
        "research",
        "budget",
        "discovery",
        "investment",
        "panel",
        "health",
        "witty",
        "system",
        "risk",
        "innovation",
        "suspension",
        "end",
        "repurchase",
        "target",
        "firepower",
        "biotechnology",
        "move",
        "half",
        "glaxos",
        "company",
        "china",
        "india",
        "payasyou",
        "contract",
        "aspen",
        "pharmacare",
        "deviate",
        "business",
        "plan"
    ],
    "category": [
        "money",
        "markets"
    ]
}